Breast Cancer Risk Reduction Strategies

Introduction

Breast cancer remains a formidable global health challenge, necessitating a comprehensive understanding of its etiology and, critically, the implementation of effective risk reduction strategies. While advancements in treatment continue to evolve, a proactive approach focusing on primary prevention holds substantial promise for mitigating its incidence and associated morbidity and mortality [1]. This paper delineates various modifiable and non-modifiable risk factors for breast cancer and outlines evidence-based interventions spanning lifestyle adjustments, medical approaches, and public health initiatives. Specifically, this review focuses on lifestyle modifications, reproductive and hormonal considerations, screening guidelines, and environmental factors that contribute to breast cancer risk reduction [2] [3].

Overview of breast cancer burden

Breast cancer is the most prevalent cancer globally, with an estimated 19.3 million new cases and nearly 10 million deaths worldwide, underscoring the urgent need for robust preventive measures [4]. The disease significantly impacts women’s health globally, with epidemiological data highlighting distinct geographic and demographic disparities in its incidence and mortality [5]. Understanding these variations is crucial for tailoring public health interventions and allocating resources effectively towards reducing the overall burden of breast cancer [4].

Importance of risk reduction

Given the substantial global burden of breast cancer, implementing effective risk reduction strategies is paramount for enhancing public health and decreasing mortality rates [4]. This includes targeted interventions for younger women, such as promoting physical activity and reducing alcohol consumption, to mitigate long-term risks [6]. Furthermore, identifying and addressing modifiable risk factors can significantly lower an individual’s susceptibility to developing breast cancer [7]. This proactive approach not only reduces the personal health burden but also alleviates the immense strain on healthcare systems worldwide [1]. Moreover, while non-modifiable factors like genetic predispositions account for a minority of cases, addressing behavioral and environmental risk factors offers a broad scope for primary prevention initiatives [8].

Lifestyle Modifications

A significant proportion of breast cancer cases are considered preventable through lifestyle modifications, with estimates suggesting that approximately 30% of cases in the US could be avoided by addressing modifiable risk factors [9]. Such interventions include maintaining a healthy weight, engaging in regular physical activity, adhering to a balanced diet, limiting alcohol intake, and avoiding smoking [10] [11].

Maintaining a healthy weight

Obesity, particularly post-menopausal obesity, is a well-established risk factor for breast cancer due to altered hormone metabolism and chronic inflammation [12] [13]. Studies indicate that a 6% increase in breast cancer risk is observed for every 5 kg of body weight gained, emphasizing the importance of weight management [14]. Therefore, maintaining a healthy body mass index through diet and exercise is a critical component of breast cancer prevention strategies [15].

Regular physical activity

Engaging in regular physical activity has been consistently linked to a reduced risk of breast cancer, with studies demonstrating that even moderate exercise can significantly lower incidence rates [6]. This protective effect is attributed to various mechanisms, including improved immune function, reduced inflammation, and favorable alterations in hormone levels [16]. For instance, consistent engagement in aerobic exercises has been shown to reduce circulating estrogen levels, thereby mitigating a key hormonal driver of breast cancer development [17].

Moreover, studies suggest that physical activity also favorably impacts insulin sensitivity and reduces chronic inflammation, both of which are implicated in breast carcinogenesis [18]. Adherence to guidelines recommending at least 150 minutes of moderate-intensity or 75 minutes of vigorous-intensity aerobic activity per week has been consistently associated with reduced breast cancer risk [19]. These benefits are hypothesized to stem from mechanisms such as body fat reduction, which subsequently lowers estrogen and insulin concentrations, both of which possess mitogenic effects on mammary cells [20]. Furthermore, regular physical activity may modulate immune system surveillance, enhancing the body’s ability to detect and eliminate nascent cancer cells [21].

Balanced diet (low fat, high fiber, fruits & vegetables)

A diet rich in fiber, fruits, and vegetables, while low in fat, is crucial for reducing breast cancer risk by influencing immunity and metabolic pathways [10]. Specifically, consuming non-starchy vegetables and carotenoids has been identified as a protective factor against breast cancer [22]. The Mediterranean diet, characterized by high intake of fruits, vegetables, and olive oil, has also been associated with a lower incidence of various cancers, including breast cancer [23]. Such dietary patterns contribute to overall metabolic health, thereby indirectly reducing cancer risk by mitigating obesity and chronic inflammation [24]. For example, lycopene, found abundantly in tomatoes, has demonstrated tumor-suppressive effects in animal models by reducing tumor incidence and size in chemically induced mammary carcinogenesis [23]. Conversely, poor eating habits and a BMI over 25 significantly elevate breast cancer risk, underscoring the importance of dietary interventions [25].

Limiting alcohol intake

Even moderate alcohol consumption is recognized as a modifiable risk factor for breast cancer, with a dose-dependent relationship observed between intake levels and increased risk [26]. This association is attributed to alcohol’s influence on estrogen metabolism and its capacity to damage DNA, even at low to moderate consumption levels. The mechanistic link involves alcohol’s role in elevating circulating estrogen levels and its direct genotoxic effects through acetaldehyde, a carcinogenic metabolite [27]. Therefore, minimizing or abstaining from alcohol intake is a direct and actionable strategy for breast cancer prevention [28].

Avoiding smoking

Tobacco use, encompassing both active smoking and exposure to secondhand smoke, is a significant, albeit often overlooked, risk factor for various cancers, including breast cancer, with studies indicating a heightened risk among smokers [29] [30]. Accumulating evidence suggests that smoking, particularly at an early age, significantly elevates the risk of breast cancer occurrence [17]. The carcinogenic compounds in tobacco smoke can induce DNA damage and promote cellular mutations, contributing to mammary carcinogenesis [25].

Furthermore, prolonged exposure to carcinogens present in cigarette smoke has been implicated in altering cellular pathways critical for maintaining genomic stability and regulating cell proliferation [17]. Consequently, the cessation of smoking is a crucial intervention for reducing breast cancer risk, particularly given the cumulative exposure effects on cellular integrity [12] [29]. It is almost certain that smoking increases the risk of developing breast cancer, and there is also probable evidence that passive smoking increases this risk [22]. This is further supported by observations that lipophilic, tobacco-related carcinogens can be stored in breast adipose tissue and subsequently activated by mammary epithelial cells, leading to p53 mutations in breast parenchyma [31]. Beyond direct carcinogenesis, nicotine, a primary component of tobacco, has been shown to induce alterations in mammary gland architecture, including increased ductal elongation and branching, which could contribute to a pro-carcinogenic microenvironment.

Moreover, certain components of tobacco smoke, such as chromium, enhance the binding of carcinogens like benzopyrene to DNA, exacerbating its damaging potential, while nickel and arsenic impede DNA repair mechanisms, fostering cancer development [32]. Additionally, genetic predispositions, such as variants in enzymes involved in carcinogen metabolism like NAT2, can modify the effect of tobacco use on breast cancer risk, with slow acetylator genotypes increasing susceptibility, especially with higher pack-years [18] [32].

Reproductive and Hormonal Factors

Breastfeeding benefits

Breastfeeding offers substantial protective benefits against breast cancer, primarily by altering hormonal exposure patterns and promoting terminal differentiation of mammary epithelial cells. This protective effect is attributed to the delay in menstrual cycles and the subsequent reduction in lifetime estrogen exposure, as well as the complete maturation of breast tissue during lactation, rendering it less susceptible to malignant transformation. Furthermore, the involution process post-lactation involves a genetic signature that promotes apoptosis and efficient DNA damage repair, thereby clearing cells with potential carcinogenic alterations [33].

Longer durations of breastfeeding are associated with a greater reduction in breast cancer risk, particularly in premenopausal women and in populations with high breastfeeding prevalence [33]. The protective effects of breastfeeding are also mediated by changes in the breast microenvironment, including reduced inflammation and oxidative stress, which further contribute to lowering cancer risk [34]. The impact of breastfeeding on reducing breast cancer risk is especially notable in women with a family history of breast cancer and those who breastfeed for extended periods [15].

Pregnancy and childbirth factors

Pregnancy and childbirth also influence breast cancer risk, with early age at first full-term pregnancy and increased parity generally associated with a reduced risk of breast cancer [17]. This protective effect is largely attributed to the permanent differentiation of mammary epithelial cells that occurs during a full-term pregnancy, rendering them less susceptible to malignant transformation [35]. Specifically, this differentiation decreases the proliferative capacity of mammary cells, thereby reducing the probability of accumulating oncogenic mutations [36]. Conversely, nulliparity, or a late age at first live birth, is associated with an elevated risk of breast cancer due to prolonged exposure to endogenous estrogens without the protective cellular differentiation induced by pregnancy [37].

Caution with hormone replacement therapy (HRT)

Hormone replacement therapy, particularly combined estrogen and progestin regimens, has been demonstrably linked to an increased risk of breast cancer, necessitating careful consideration of its use and duration. This elevated risk is attributed to the proliferation-stimulating effects of exogenous hormones on mammary epithelial cells, potentially accelerating the growth of existing microscopic tumors or initiating new ones. The increased risk associated with HRT is dose and duration-dependent, highlighting the importance of prescribing the lowest effective dose for the shortest possible duration to manage menopausal symptoms [10].

Oral contraceptive considerations

The use of oral contraceptives presents a complex relationship with breast cancer risk, with studies indicating varying effects depending on factors such as formulation, duration of use, and a woman’s overall risk profile [1] [38]. While some research indicates a slight increase in risk with current or recent oral contraceptive use, this elevation often diminishes over time after cessation, with no significant increase observed after 10 years [39]. The risk is also influenced by the specific estrogen and progestin components within the contraceptive formulation, with some combinations potentially carrying a higher risk than others [17]. This nuanced relationship necessitates a thorough evaluation of individual patient characteristics, including age at menarche, age at first delivery, and parity, when assessing the overall impact of hormonal contraception on breast cancer risk [40] [41].

Screening and Early Detection

Breast self-examination awareness

Regular breast self-examination can empower women to become familiar with the normal consistency of their breast tissue, enabling them to detect subtle changes that may warrant further medical evaluation. While not a primary screening tool for asymptomatic women, consistent self-awareness can facilitate earlier presentation for clinical assessment, potentially leading to the detection of abnormalities at a more treatable stage. Furthermore, educational initiatives aimed at promoting proper self-examination techniques are crucial for enhancing diagnostic accuracy and reducing false positives. However, knowledge regarding the correct practice and importance of breast self-examination remains low among many women [42]. Therefore, targeted educational programs are essential to improve understanding and proficiency in performing breast self-examinations effectively.

Clinical breast exams

Clinical breast examinations, performed by a trained healthcare professional, offer another vital layer of early detection by systematically assessing breast tissue for any palpable masses or abnormalities that may not be evident through self-examination. These examinations are particularly crucial for women who may not have access to regular mammography or for identifying suspicious lesions that warrant further imaging or biopsy [43].

For instance, the presence of a dominant lump, skin changes, or nipple discharge observed during a clinical breast exam necessitates immediate follow-up to differentiate benign conditions from potential malignancies. Moreover, annual clinical breast exams are recommended for women of average risk as part of their routine check-ups [25]. The efficacy of clinical breast exams is enhanced when performed by experienced practitioners who can differentiate between normal breast variations and potentially pathological findings, thus minimizing unnecessary follow-up procedures. Regular participation in screening programs, including clinical breast exams, is associated with a higher likelihood of early detection for various breast cancer subtypes, leading to improved prognoses [1].

Mammography guidelines

Mammography remains the cornerstone of breast cancer screening, utilizing low-dose X-rays to detect abnormalities such as microcalcifications or masses that may indicate early-stage cancer, often before they are palpable [25]. Several prominent organizations, including the American College of Radiology and the U.S. Preventive Services Task Force, issue comprehensive guidelines recommending regular mammographic screening for women, typically starting at age 40 or 50, depending on individual risk factors [25] [44]. These guidelines emphasize that regular mammograms can significantly reduce breast cancer-related mortality by enabling detection at an early, more treatable stage [45]. For women over 40, annual mammography in conjunction with clinical breast examination is a recommended screening approach for women at average risk for breast cancer, which is considered the gold standard in the US [25].

Genetic testing for BRCA mutations

Genetic testing for BRCA1 and BRCA2 mutations is recommended for individuals with a strong family history of breast or ovarian cancer, as these mutations significantly increase lifetime risk. This testing allows for personalized risk assessment and informs prophylactic measures, such as enhanced surveillance or risk-reducing surgeries, for high-risk individuals [46]. The identification of such mutations enables targeted interventions and can guide treatment decisions, including the use of specific chemotherapeutic agents or PARP inhibitors, for individuals already diagnosed with breast cancer. Furthermore, advancements in high-throughput genomic and proteomic approaches are becoming increasingly important for assessing expression of multiple biomarkers simultaneously, moving beyond single-marker analyses for a more comprehensive understanding of disease prognosis and treatment response [23].

Medical and Surgical Interventions

Preventive (prophylactic) medications (e.g., tamoxifen)

(e.g., tamoxifen) such as selective estrogen receptor modulators and aromatase inhibitors, are pharmacological agents employed to reduce the risk of breast cancer in high-risk women [27]. These medications, including tamoxifen, primarily target estrogen receptor-positive tumors by blocking estrogen’s proliferative effects on breast tissue, thereby mitigating the hormonal drive for carcinogenesis [29].

For instance, tamoxifen has demonstrated efficacy in reducing the incidence of invasive breast cancer in high-risk pre- and postmenopausal women, whereas aromatase inhibitors are typically reserved for postmenopausal women [29]. Lower doses of tamoxifen, such as 2.5 mg or 5 mg, have shown comparable effectiveness in reducing breast density and cancer risk with significantly improved tolerability and fewer side effects, making it a viable option for a broader range of high-risk women [10]. However, the decision to initiate chemoprevention should involve a comprehensive discussion between the patient and healthcare provider, weighing the potential benefits against the risks of side effects.

Prophylactic mastectomy and oophorectomy in high-risk women

For individuals identified with BRCA1/2 mutations, these prophylactic surgeries significantly reduce the risk of developing breast and ovarian cancers, respectively, offering a crucial preventative strategy [47] [48]. However, while risk-reducing salpingo-oophorectomy effectively lowers ovarian cancer risk, its impact on breast cancer risk for BRCA1 mutation carriers is less certain, with some studies suggesting a beneficial effect primarily for BRCA2 mutation carriers [24]. Despite these benefits, prophylactic surgeries present significant physical and psychological implications, necessitating careful consideration of individual patient preferences, reproductive plans, and quality of life [10].

Moreover, surgical modifications, such as those made to standard modified radical mastectomy, have focused on reducing short-term morbidity while maintaining oncological efficacy [49]. Furthermore, risk-reducing bilateral mastectomy is not indicated in the absence of clearly defined genetic risk factors [48]. Such interventions, therefore, require a thorough genetic risk assessment, often guided by the presence of a strong family history or known pathogenic variants [16]. The comprehensive evaluation of a patient’s genetic profile and family history is critical for determining eligibility for prophylactic interventions, especially given the distinct risks and benefits associated with each procedure [50]. This individualized approach ensures that the chosen intervention aligns with the patient’s overall health status, genetic predisposition, and personal values.

Environmental and Occupational Factors

Reducing exposure to radiation

Minimizing exposure to ionizing radiation, particularly during critical developmental periods, is crucial given its established role as a carcinogen in breast tissue. This includes careful consideration of medical imaging procedures, such as X-rays and CT scans, especially for younger individuals, and implementing stringent safety protocols in occupational settings with potential radiation exposure.

Minimizing carcinogen exposure

Limiting exposure to various environmental and occupational carcinogens, including certain chemicals and pollutants, is another vital component of breast cancer risk reduction strategies. This involves promoting public health initiatives that regulate industrial emissions and advocating for safer practices in workplaces to reduce contact with known or suspected breast carcinogens. Moreover, public awareness campaigns play a pivotal role in educating individuals about common household and environmental toxins, enabling informed choices to mitigate exposure.

Psychosocial and Community Awareness

Education and awareness campaigns

These initiatives are crucial for empowering individuals with knowledge about breast cancer risk factors, symptoms, and the importance of early detection and personalized prevention strategies [16]. Such campaigns often leverage diverse media channels to disseminate information regarding lifestyle modifications, genetic counseling, and screening protocols, thereby fostering a proactive approach to breast health within communities [16]. Furthermore, they can promote engagement with healthcare providers to discuss personalized risk assessment and appropriate screening schedules.

Support groups and counseling

These resources provide essential emotional and psychological support for individuals undergoing breast cancer treatment or facing elevated risk, helping to mitigate the psychosocial burdens associated with the disease [6] [1]. They also offer a platform for sharing experiences and coping mechanisms, thereby enhancing resilience and promoting mental well-being among affected populations. These support systems can also facilitate informed decision-making regarding preventive measures and treatment options, fostering a sense of community and reducing feelings of isolation [18].

Conclusion

Summary of key strategies

The comprehensive approach to breast cancer prevention encompasses a multifaceted strategy, ranging from lifestyle modifications and early detection to advanced medical and surgical interventions tailored to individual risk profiles [51] [16]. This holistic perspective integrates insights from environmental health, genetic predispositions, and psychosocial support systems, acknowledging that diverse factors contribute to breast cancer etiology and progression [52] [53]. Therefore, primary prevention strategies that address modifiable risk factors at a population level are increasingly recognized as essential for reducing breast cancer incidence [54].

Emphasis on multi-factor approach to prevention

This multi-faceted approach underscores the necessity of interdisciplinary collaboration and public health initiatives to effectively implement strategies that address the complex interplay of genetic, environmental, and lifestyle determinants of breast cancer risk [55]. Such an integrated strategy supports the paradigm shift towards personalized medicine, optimizing interventions across a woman’s lifespan to reduce breast cancer incidence and mortality [10]. Emerging technologies, including artificial intelligence and machine learning, are poised to further enhance precision in cancer control and prevention by enabling accurate monitoring of patient health statuses and early detection [4]. These advanced computational methods can also generate insights by predicting behavioral changes in high-risk individuals, thereby informing more effective intervention strategies [4]. Furthermore, advancements in genomics and digital imaging facilitate personalized approaches for early detection and prevention, although their widespread implementation requires addressing significant ethical, legal, social, and organizational challenges [56].

REFERENCES:

1.

Vidali S, Susini T. Breast Cancer Risk and Prevention: A Step Forward. Cancers [Internet]. 2023 Nov 23 [cited 2025 Jun];15(23):5559. Available from: https://doi.org/10.3390/cancers15235559

2.

Lilleborge M, Falk RS, Sørlie T, Ursin G, Hofvind S. Can breast cancer be stopped? Modifiable risk factors of breast cancer among women with a prior benign or premalignant lesion. International Journal of Cancer [Internet]. 2021 May 15 [cited 2025 Aug];149(6):1247. Available from: https://doi.org/10.1002/ijc.33680

3.

Cohen SY, Stoll C, Anandarajah A, Doering M, Colditz GA. Modifiable risk factors in women at high risk of breast cancer: a systematic review. Breast Cancer Research [Internet]. BioMed Central; 2023 Apr 24 [cited 2025 Sep];25(1). Available from: https://doi.org/10.1186/s13058-023-01636-1

4.

Musa IH, Afolabi LO, Zamit I, Musa TH, Musa HH, Tassang A, et al. Artificial Intelligence and Machine Learning in Cancer Research: A Systematic and Thematic Analysis of the Top 100 Cited Articles Indexed in Scopus Database. Cancer Control [Internet]. 2022 Jun 10 [cited 2025 Sep];29. Available from: https://doi.org/10.1177/10732748221095946

5.

Xu H, Xu B. Breast cancer: Epidemiology, risk factors and screening. Chinese Journal of Cancer Research [Internet]. 2023 Jan 1 [cited 2025 Sep];35(6):565. Available from: https://doi.org/10.21147/j.issn.1000-9604.2023.06.02

6.

Cai Y, Dai F, Ye Y, Qian JX. The global burden of breast cancer among women of reproductive age: a comprehensive analysis. Scientific Reports [Internet]. 2025 Mar 18 [cited 2025 Aug];15(1). Available from: https://doi.org/10.1038/s41598-025-93883-9

7.

Mustafa M, Sarfraz S, Saleem G, Khan TA, Shahid D, Taj S, et al. Beyond Milk and Nurture: Breastfeeding’s Powerful Impact on Breast Cancer. Geburtshilfe und Frauenheilkunde [Internet]. 2024 Jun 1 [cited 2025 Sep];84(6):541. Available from: https://doi.org/10.1055/a-2313-0637

8.

Şenödeyici E. Editorial. TURKISH MEDICAL STUDENT JOURNAL [Internet]. 2024 Oct 28 [cited 2025 Aug]; Available from: https://doi.org/10.4274/tmsj.galenos.2024.281024

9.

Vegunta S, Lester SP, Pruthi S, Mussallem DM. Effects of major lifestyle factors on breast cancer risk: impact of weight, nutrition, physical activity, alcohol and tobacco. Breast Cancer Management [Internet]. 2020 Sep 30 [cited 2025 Sep];9(4). Available from: https://doi.org/10.2217/bmt-2020-0033

10.

Leggat-Barr K, Yee D, Duralde E, Hodge C, Borges VF, Baxter M, et al. A roadmap to reduce the incidence and mortality of breast cancer by rethinking our approach to women’s health. Breast Cancer Research and Treatment [Internet]. Springer Science+Business Media; 2024 Nov 12 [cited 2025 Aug]; Available from: https://doi.org/10.1007/s10549-024-07522-4

11.

Manni A, El‐Bayoumy K. Lifestyle Modifications and Breast Cancer Risk. Cancers [Internet]. 2023 May 23 [cited 2025 Sep];15(11):2870. Available from: https://doi.org/10.3390/cancers15112870

12.

Ahmed Z. Risk factors in breast cancer: can we change something. MOJ Surgery [Internet]. 2019 Feb 20 [cited 2025 Sep];7(1). Available from: https://doi.org/10.15406/mojs.2019.07.00154

13.

Coughlin SS. The Impact of the Natural, Social, Built, and Policy Environments on Breast Cancer. JOURNAL OF ENVIRONMENT AND HEALTH SCIENCE [Internet]. 2015 Jul 30 [cited 2025 Aug];1. Available from: https://doi.org/10.15436/2378-6841.15.020

14.

Mubarik S, Malik SS, Yanran Z, Hak E, Nawsherwan N, Wang F, et al. Estimating disparities in breast cancer screening programs towards mortality, case fatality, and DALYs across BRICS-plus. BMC Medicine [Internet]. 2023 Sep 1 [cited 2025 Aug];21(1). Available from: https://doi.org/10.1186/s12916-023-03004-4

15.

Roheel A, Khan A, Anwar F, Akbar Z, Akhtar MF, Khan MI, et al. Global epidemiology of breast cancer based on risk factors: a systematic review. Frontiers in Oncology [Internet]. Frontiers Media; 2023 Oct 10 [cited 2025 Aug];13. Available from: https://doi.org/10.3389/fonc.2023.1240098

16.

Pashayan N, Antoniou AC, Ivanuš U, Esserman LJ, Easton DF, French D, et al. Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nature Reviews Clinical Oncology [Internet]. Nature Portfolio; 2020 Jun 18 [cited 2025 Aug];17(11):687. Available from: https://doi.org/10.1038/s41571-020-0388-9

17.

Sun YS, Zhao Z, Yang ZN, Fang X, Lu HJ, Zhu ZY, et al. Risk Factors and Preventions of Breast Cancer. International Journal of Biological Sciences [Internet]. Ivyspring International Publisher; 2017 Jan 1 [cited 2025 Aug];13(11):1387. Available from: https://doi.org/10.7150/ijbs.21635

18.

Obeidat O, Charles K, Akhter N, Tong A. Social Risk Factors That Increase Cardiovascular and Breast Cancer Risk. Current Cardiology Reports [Internet]. Springer Science+Business Media; 2023 Oct 1 [cited 2025 Aug];25(10):1269. Available from: https://doi.org/10.1007/s11886-023-01957-9

19.

Colditz GA, Wolin KY, Gehlert S. Applying What We Know to Accelerate Cancer Prevention. Science Translational Medicine [Internet]. American Association for the Advancement of Science; 2012 Mar 28 [cited 2025 Aug];4(127). Available from: https://doi.org/10.1126/scitranslmed.3003218

20.

Silva DAS, Tremblay MS, Souza M de FM de, Guerra MR, Mooney M, Naghavi M, et al. Mortality and years of life lost due to breast cancer attributable to physical inactivity in the Brazilian female population (1990–2015). Scientific Reports [Internet]. 2018 Jul 18 [cited 2025 Aug];8(1). Available from: https://doi.org/10.1038/s41598-018-29467-7

21.

Starek‐Świechowicz B, Budziszewska B, Stárek A. Endogenous estrogens—breast cancer and chemoprevention. Pharmacological Reports [Internet]. Elsevier BV; 2021 Aug 30 [cited 2025 Aug];73(6):1497. Available from: https://doi.org/10.1007/s43440-021-00317-0

22.

Kawai M, Ohtani S, Iwasaki M, Yamamoto S, Takamatsu K, Okamura H, et al. The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2022 edition. Breast Cancer [Internet]. 2023 Dec 26 [cited 2025 Jul];31(2):166. Available from: https://doi.org/10.1007/s12282-023-01531-9

23.

Rao AV, Ray MR, Rao LG. LYCOPENE. 2006.

24.

Thill M, Janni W, Albert U, Banys‐Paluchowski M, Bartsch R, Bauerfeind I, et al. AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2025. Breast Care [Internet]. Karger Publishers; 2025 Mar 8 [cited 2025 Aug];1. Available from: https://doi.org/10.1159/000545018

25.

Barba D, León-Sosa A, Lugo P, Suquillo D, Torres F, Surre F, et al. Breast cancer, screening and diagnostic tools: All you need to know. Critical Reviews in Oncology/Hematology [Internet]. Elsevier BV; 2020 Nov 11 [cited 2025 Aug];157:103174. Available from: https://doi.org/10.1016/j.critrevonc.2020.103174

26.

Kerr J, Anderson CAM, Lippman SM. Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence. The Lancet Oncology [Internet]. Elsevier BV; 2017 Jul 26 [cited 2025 Aug];18(8). Available from: https://doi.org/10.1016/s1470-2045(17)30411-4

27.

Shanazarov N, Zhapparov Y, Kumisbekova RK, Turzhanova D, Zulkhash N. Association of Gene Polymorphisms with Breast Cancer Risk in the Kazakh Population. Asian Pacific Journal of Cancer Prevention [Internet]. 2023 Dec 1 [cited 2025 Aug];24(12):4195. Available from: https://doi.org/10.31557/apjcp.2023.24.12.4195

28.

Sewani A. Breast Cancer: Causes, Risk Factors and Prevention. The Anthropologist [Internet]. 2001 Apr 1 [cited 2025 Feb];3(2):131. Available from: https://doi.org/10.1080/09720073.2001.11890701

29.

Panda P. BREAST CANCER BIOMARKERS: A Review. 2024.

30.

Hashemi SHB, Karimi S, Mahboobi H. Lifestyle changes for prevention of breast cancer. DOAJ (DOAJ: Directory of Open Access Journals) [Internet]. 2015 Mar 13 [cited 2025 Jul];6(3):894. Available from: https://doaj.org/article/5f961a3c23df4412a13787249c63cda8

31.

Daniele A, Divella R, Pilato B, Tommasi S, Pasanisi P, Patruno M, et al. Can harmful lifestyle, obesity and weight changes increase the risk of breast cancer in BRCA 1 and BRCA 2 mutation carriers? A Mini review. Hereditary Cancer in Clinical Practice [Internet]. BioMed Central; 2021 Oct 27 [cited 2025 Aug];19(1). Available from: https://doi.org/10.1186/s13053-021-00199-6

32.

Akhoundi M, Chebbah D, Séréno D, Marteau A, Jan J, Bruel C, et al. International Journal of Environmental Research and Public Health. International Journal of Environmental Research and Public Health [Internet]. 2013 Feb 12 [cited 2025 Sep]; Available from: https://doi.org/10.3390/ijerph

33.

Chen Y, Jiang P, Geng Y. The role of breastfeeding in breast cancer prevention: a literature review. Frontiers in Oncology [Internet]. Frontiers Media; 2023 Sep 7 [cited 2025 Aug];13. Available from: https://doi.org/10.3389/fonc.2023.1257804

34.

Sözen S, Emir S. Breast Cancer Updates [Internet]. IntechOpen eBooks. IntechOpen; 2022 [cited 2025 Aug]. Available from: https://doi.org/10.5772/intechopen.104150

35.

Kamińska M, Ciszewski T, Łopacka-Szatan K, Miotła P, Starosławska E. Breast cancer risk factors. Menopausal Review [Internet]. Termedia Publishing House; 2015 Jan 1 [cited 2025 Sep];3:196. Available from: https://doi.org/10.5114/pm.2015.54346

36.

Hernández-García M, Molina‐Barceló A, Vanaclocha‐Espí M, Zurriaga Ó, Pérez‐Gómez B, Aragonés N, et al. Differences in breast cancer-risk factors between screen-detected and non-screen-detected cases (MCC-Spain study). Cancer Causes & Control [Internet]. 2021 Nov 24 [cited 2025 Aug];33(1):125. Available from: https://doi.org/10.1007/s10552-021-01511-4

37.

Shi M, O’Brien KM, Weinberg CR. Interactions between a Polygenic Risk Score and Non-genetic Risk Factors in Young-Onset Breast Cancer. Scientific Reports [Internet]. 2020 Feb 24 [cited 2025 Aug];10(1). Available from: https://doi.org/10.1038/s41598-020-60032-3

38.

Almasi‐Hashiani A, Nedjat S, Ghiasvand R, Safiri S, Nazemipour M, Mansournia N, et al. The causal effect and impact of reproductive factors on breast cancer using super learner and targeted maximum likelihood estimation: a case-control study in Fars Province, Iran. BMC Public Health [Internet]. 2021 Jun 24 [cited 2025 Aug];21(1). Available from: https://doi.org/10.1186/s12889-021-11307-5

39.

Romieu I, Biessy C, Carayol M, His M, Torres-Mejı́a G, Ángeles-Llerenas A, et al. Reproductive factors and molecular subtypes of breast cancer among premenopausal women in Latin America: the PRECAMA study. Scientific Reports [Internet]. 2018 Aug 24 [cited 2025 Aug];8(1). Available from: https://doi.org/10.1038/s41598-018-31393-7

40.

Satish S, Moore JF, Littlefield JM, Bishop IJ, Rojas KE. Re-Evaluating the Association Between Hormonal Contraception and Breast Cancer Risk. Breast Cancer Targets and Therapy [Internet]. Dove Medical Press; 2023 Mar 1 [cited 2025 Aug];227. Available from: https://doi.org/10.2147/bctt.s390664

41.

Casey PM, Cerhan JR, Pruthi S. Oral Contraceptive Use and the Risk of Breast Cancer. Mayo Clinic Proceedings [Internet]. Elsevier BV; 2008 Jan 1 [cited 2025 Aug];83(1):86. Available from: https://doi.org/10.4065/83.1.86

42.

Prusty RK, Begum S, Patil A, Naik DD, Pimple S, Mishra G. Knowledge of symptoms and risk factors of breast cancer among women: a community based study in a low socio-economic area of Mumbai, India. BMC Women s Health [Internet]. 2020 May 18 [cited 2025 Aug];20(1). Available from: https://doi.org/10.1186/s12905-020-00967-x

43.

Malik S, Waquar S, Idrees N, Malik AS. Impending role of inflammatory markers and their specificity and sensitivity in breast cancer patients. Scientific Reports [Internet]. 2024 Jul 2 [cited 2025 Aug];14(1). Available from: https://doi.org/10.1038/s41598-024-65821-8

44.

Katsika L, Boureka E, Kalogiannidis I, Tsakiridis Ι, Tirodimos I, Lallas K, et al. Screening for Breast Cancer: A Comparative Review of Guidelines. Life [Internet]. Multidisciplinary Digital Publishing Institute; 2024 Jun 19 [cited 2025 Aug];14(6):777. Available from: https://doi.org/10.3390/life14060777

45.

Pataki J, Dombrádi V, Sárváry A, Szöllösi GJ. Breast cancer screening and its associating factors among hungarian women aged 45–65: a cross-sectional study based on the European health interview surveys from 2009 to 2019. BMC Public Health [Internet]. 2023 Aug 31 [cited 2025 Aug];23(1). Available from: https://doi.org/10.1186/s12889-023-16608-5

46.

Menes TS, Zippel D, Sklair‐Levy M, Friedman E, Bernstein‐Molho R, Faermann R, et al. Clinical breast exam contribution to breast cancer diagnosis in BRCA mutation carriers vs. average to intermediate risk women. Breast Cancer Research and Treatment [Internet]. 2024 May 26 [cited 2025 Aug];207(1):111. Available from: https://doi.org/10.1007/s10549-024-07345-3

47.

Pescia C, Guerini‐Rocco E, Viale G, Fusco N. Advances in Early Breast Cancer Risk Profiling: From Histopathology to Molecular Technologies. Cancers [Internet]. Multidisciplinary Digital Publishing Institute; 2023 Nov 15 [cited 2025 Aug];15(22):5430. Available from: https://doi.org/10.3390/cancers15225430

48.

Park‐Simon T, Müller V, Albert U, Banys-Paluchowski M, Bartsch R, Bauerfeind I, et al. AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2025. Breast Care [Internet]. Karger Publishers; 2025 Mar 8 [cited 2025 Aug];1. Available from: https://doi.org/10.1159/000545019

49.

Bandyopadhyay A, Talwar R, Patel A, Jaiswal P. The modifications in surgical technique and its impact on short term morbidity in modified radical mastectomy: a tertiary care hospital experience. International Surgery Journal [Internet]. 2019 Nov 26 [cited 2025 May];6(12):4354. Available from: https://doi.org/10.18203/2349-2902.isj20195393

50.

Manchanda R, Lieberman S, Gaba F, Lahad A, Levy‐Lahad E. Population Screening for Inherited Predisposition to Breast and Ovarian Cancer. Annual Review of Genomics and Human Genetics [Internet]. Annual Reviews; 2020 Apr 21 [cited 2025 Jul];21(1):373. Available from: https://doi.org/10.1146/annurev-genom-083118-015253

51.

Requejo-Mas AL, Bustamante-Bustamante EL, Silva-Díaz H. Attitudes and preventive practices against breast cancer in mothers of a school in Tuman, Peru, 2022. Gaceta Mexicana de Oncología [Internet]. 2023 Oct 3 [cited 2025 Jul];22(4). Available from: https://doi.org/10.24875/j.gamo.m23000250

52.

Liao L. Inequality in Breast Cancer: Global Statistics from 2022 to 2050. The Breast [Internet]. 2024 Nov 22 [cited 2025 Aug];79:103851. Available from: https://doi.org/10.1016/j.breast.2024.103851

53.

Wright KB, Fisher CL, Rising CJ, Burke‐Garcia A, Afanaseva D, Cai X. Partnering With Mommy Bloggers to Disseminate Breast Cancer Risk Information: Social Media Intervention. Journal of Medical Internet Research [Internet]. 2018 Dec 15 [cited 2025 Aug];21(3). Available from: https://doi.org/10.2196/12441

54.

White MC, Lynch M, Davis-Patterson S, Buermeyer N. An Expanded Agenda for the Primary Prevention of Breast Cancer: Charting a Course for the Future. International Journal of Environmental Research and Public Health [Internet]. 2020 Jan 22 [cited 2025 Feb];17(3):714. Available from: https://doi.org/10.3390/ijerph17030714

55.

Richter L. Challenging dominant breast cancer research agendas: perspectives on the outcomes of the interagency breast cancer and environment research coordinating committee. Environmental Health [Internet]. 2019 May 6 [cited 2025 Aug];18(1). Available from: https://doi.org/10.1186/s12940-019-0479-1

56.

Nabi H. Personalized Approaches for the Prevention and Treatment of Breast Cancer. Journal of Personalized Medicine [Internet]. 2022 Jul 23 [cited 2025 Aug];12(8):1201. Available from: https://doi.org/10.3390/jpm12081201